scholarly article | Q13442814 |
P50 | author | Alchiede Simonato | Q57054853 |
Marco Vella | Q59160465 | ||
Elena Lo Presti | Q86283211 | ||
P2093 | author name string | Serena Meraviglia | |
Cristina Scalici Gesolfo | |||
Vincenzo Serretta | |||
Alberto Abrate | |||
Daniela Coniglio | |||
P2860 | cites work | Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases | Q27645000 |
Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma | Q28386704 | ||
Thymic maturation determines gammadelta T cell function, but not their antigen specificities | Q28389313 | ||
Antigen-Presenting Human γδ T Cells Promote Intestinal CD4+ T Cell Expression of IL-22 and Mucosal Release of Calprotectin | Q33567987 | ||
Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages | Q34119854 | ||
The influence of finasteride on the development of prostate cancer | Q34534815 | ||
Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters | Q34605766 | ||
20-year outcomes following conservative management of clinically localized prostate cancer | Q36115855 | ||
Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites | Q36371370 | ||
Inflammation in prostate carcinogenesis | Q36554784 | ||
Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer | Q36800215 | ||
The prognostic landscape of genes and infiltrating immune cells across human cancers | Q36857285 | ||
Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human Vδ3 T cells. | Q37039445 | ||
Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes | Q37269077 | ||
Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+. | Q37435472 | ||
Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma | Q37473297 | ||
Current progress in γδ T-cell biology. | Q37729208 | ||
Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells | Q37731978 | ||
γδ T-APCs: a novel tool for immunotherapy? | Q37875768 | ||
The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy | Q38347451 | ||
IL-17A produced by γδ T cells promotes tumor growth in hepatocellular carcinoma. | Q39024081 | ||
CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients | Q40212457 | ||
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study. | Q40474302 | ||
Characterization of infiltrating lymphocytes in human benign and malignant prostate tissue | Q41694140 | ||
Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing | Q41953761 | ||
Decreased Vδ2 γδ T cells associated with liver damage by regulation of Th17 response in patients with chronic hepatitis B. | Q42284376 | ||
Gammadelta T cells for immune therapy of patients with lymphoid malignancies | Q44353687 | ||
Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo. | Q44575984 | ||
A subset of IL-10-producing gammadelta T cells protect the liver from Listeria-elicited, CD8(+) T cell-mediated injury. | Q52851254 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | biopsy | Q179991 |
urology | Q105650 | ||
P304 | page(s) | 91-98 | |
P577 | publication date | 2019-02-26 | |
P1433 | published in | Investigative and clinical urology | Q27727133 |
P1476 | title | Characterization of human infiltrating and circulating gamma-delta T cells in prostate cancer | |
P478 | volume | 60 |
Q97653023 | Cancer immunotherapy with γδ T cells: many paths ahead of us | cites work | P2860 |
Search more.